Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic

Table 2 Summary of included variables in scoring methods for non-alcoholic fatty liver disease

	NAFLD Fibrosis Score	Fibrotest	FIB-4	ELF	BARD	NICE	NASH test
Age	×	×	×	×			×
BMI	×				×
AST	×		×		×		×
ALT	×		×		×	x	×
Platelet Count	×		×
Albumin	×
α2-MG		×					×
Total bilirubin		×					×
Apo A1		×					×
GGT		×					×
PIIINP				×
HA				×
TIMP				×
DM					×
MS						×
CK-18						×
Sex							×
Height							×
Weight							×
HG							×
TGL							×
CL							×

α2-MG: α2 macroglobulin; ALT: Alanine aminotransferase; ApoA1: Apolipoprotein A1; AST: Aspartate aminotransferase; BMI: Body mass index; CK-18: Cytokeratin-18; CL: Cholesterol levels; DM: Diabetes mellitus; ELF: European Liver Fibrosis Test; GGT: Gamma-glutamyl transpeptidase; HA: Hyaluronic acid; HG: Haptoglobin; MS: Metabolic syndrome; PIIINP: Aminoterminal propeptide of type III collagen; TGL: Triglyceride levels; TIMP: Tissue inhibitor of metalloproteinases; NASH: Nonalcoholic steatohepatitis.